PVG Asset Management’s GSK GSK Stock Holding History

PVG Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$609K	Buy	+12,855	New	+$686K	1.44%	19
2019 Q4	–	Sell	-19,415	Closed	-$1.04M	–	75
2019 Q3	$1.04M	Sell	19,415 -1,277	-6%	-$65.7K	1.12%	29
2019 Q2	$1.03M	Sell	20,692 -2,889	-12%	-$145K	1.09%	29
2019 Q1	$1.23M	Sell	23,581 -99	-0.4%	-$4.95K	1.11%	27
2018 Q4	$1.13M	Sell	23,680 -16,122	-41%	-$794K	1.11%	34
2018 Q3	$2M	Buy	39,802 +16,047	+68%	+$815K	1.43%	19
2018 Q2	$1.2M	Sell	23,755 -2,951	-11%	-$149K	0.71%	47
2018 Q1	$1.3M	Sell	26,706 -149,654	-85%	-$6.97M	0.73%	39
2017 Q4	$7.82M	Buy	176,360 +132,736	+304%	+$6.13M	3.57%	6
2017 Q3	$2.21M	Sell	43,624 -5,001	-10%	-$254K	0.97%	31
2017 Q2	$2.62M	Sell	48,625 -29,898	-38%	-$1.59M	0.99%	34
2017 Q1	$4.14M	Sell	78,523 -70,719	-47%	-$3.59M	1.28%	26
2016 Q4	$7.18M	Buy	149,242 +104,952	+237%	+$5.18M	3.02%	7
2016 Q3	$2.39M	Buy	44,290 +940	+2%	+$51.5K	1.01%	35
2016 Q2	$2.35M	Sell	43,350 -1,346	-3%	-$70.9K	0.97%	36
2016 Q1	$2.27M	Buy	+44,696	New	+$2.23M	0.89%	42

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

PVG Asset Management's GSK Position: Q1 2020 in Review

PVG Asset Management opened a new position in GSK (GSK) in Q1 2020: 12,855 shares worth $609K. The stake represents 1.44% of the portfolio and ranks #19 among its holdings. This is a return to the name: PVG Asset Management previously reported a position in GSK as recently as Q3 2019.

PVG Asset Management first reported a position in GSK in Q1 2016 and has held it in 16 quarters since. The position peaked at $7.82M in Q4 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

PVG Asset Management held 12,855 shares of GSK worth $609K as of Q1 2020.
GSK was a new PVG Asset Management position in Q1 2020.
GSK made up 1.44% of PVG Asset Management's portfolio in Q1 2020, its #19 holding.
PVG Asset Management first reported a position in GSK in Q1 2016 and has held it in 16 quarters since.
PVG Asset Management's GSK position peaked at $7.82M in Q4 2017.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on PVG Asset Management's 13F filing for Q1 2020, filed 15 May 2020.